Unlike the entire group of variants, the baseline MAF of TP53 variants was not associated with clinical characteristics such as tumor size (cT), nodal status (cN and pN), stage, grade or RCB score (Supplementary Table S8). This evidence concerns the gene TP53 and neoplasm.